We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

American Bio Medica Corporation (Symbol:ABMC) SWOT Analysis, Strategy, Revenues and Profits

American Bio Medica Corporation (Symbol:ABMC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. American Bio Medica Corporation SWOT Analysis report provides you ...

Industries: Drug and Medication | Countries: United States

BDI Pharma, Inc. SWOT Analysis, Strategy, Revenues and Profits

BDI Pharma, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Drug and Medication | Countries: United States

Hi-Tech Pharmacal Co., Inc. (Symbol:HITK) SWOT Analysis, Strategy, Revenues and Profits

Hi-Tech Pharmacal Co., Inc. (Symbol:HITK) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Hi-Tech Pharmacal Co., Inc. SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: United States

NuPathe Inc. (Symbol:PATH) SWOT Analysis, Strategy, Revenues and Profits

NuPathe Inc. (Symbol:PATH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. NuPathe Inc. SWOT Analysis report provides you a strategic analysis ...

Industries: Drug and Medication | Countries: United States

Pharmanet Group Ltd (Symbol:PNO) SWOT Analysis, Strategy, Revenues and Profits

Pharmanet Group Ltd (Symbol:PNO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Pharmanet Group Ltd SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: United States, Australia, India

Ventrus Biosciences, Inc. (VTUS) - Financial and Strategic SWOT Analysis Review

Ventrus Biosciences, Inc. (VTUS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary Ventrus Biosciences, Inc. (Ventrus) is a pharmaceutical company. The company develops and commercializes pharmaceutical drug products used in the treatment of gastrointestinal disorders such as anal fissures, and fecal incontinence. Its products under clinical development include VEN 307, and ...

Industries: Drug and Medication | Countries: United States

Smruthi Organics Limited (Symbol:590046) SWOT Analysis, Strategy, Revenues and Profits

Smruthi Organics Limited (Symbol:590046) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Smruthi Organics Limited SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: United States

Teva Pharmaceuticals USA, Inc. SWOT Analysis, Strategy, Revenues and Profits

Teva Pharmaceuticals USA, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Drug and Medication | Countries: United States

Sagent Pharmaceuticals, Inc. (SGNT) - Financial and Strategic SWOT Analysis Review

Sagent Pharmaceuticals, Inc. (SGNT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary Sagent Pharmaceuticals, Inc. (Sagent) is a pharmaceutical company. The company develops, manufactures, and markets injectable pharmaceutical products. Its products include acetazolamide, amiodarone hcl, ampicillin, atracurium besylate, azithromycin, caffeine citrate, carboplatin, propofol, rocuronium ...

Industries: Drug and Medication | Countries: United States

BG Medicine, Inc. (BGMD) - Financial and Strategic SWOT Analysis Review

BG Medicine, Inc. (BGMD) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary BG Medicine, Inc. (BGM) is a life science company. The company discovers, develops and delivers diagnostic solutions to aid in the clinical management of heart failure and related disorders. Its product includes BGM Galectin-3. Its BGM Galectin-3 is a diagnostic test, which measures galectin-3 ...

Industries: Drug and Medication | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.